Amendment and Mail Process Complete

BAYER

Bayer Aktiengesellschaft

Amendment and Mail Process Complete

Trademark Snap Shot Amendment & Mail Processing Stylesheet
(Table presents the data on Amendment & Mail Processing Complete)

OVERVIEW

SERIAL NUMBER 86046217 FILING DATE 08/23/2013
REG NUMBER 0000000 REG DATE N/A
REGISTER PRINCIPAL MARK TYPE TRADEMARK
INTL REG # N/A INTL REG DATE N/A
TM ATTORNEY BUNCH, TASHIA AUNGELIK
L.O. ASSIGNED 105

PUB INFORMATION

RUN DATE 05/16/2014
PUB DATE N/A
STATUS 661-RESPONSE AFTER NON-FINAL-ACTION-ENTERED
STATUS DATE 05/15/2014
LITERAL MARK ELEMENT BAYER

DATE ABANDONED N/A DATE CANCELLED N/A
SECTION 2F NO SECTION 2F IN PART NO
SECTION 8 NO SECTION 8 IN PART NO
SECTION 15 NO REPUB 12C N/A
RENEWAL FILED NO RENEWAL DATE N/A
DATE AMEND REG N/A


FILING BASIS

FILED BASIS CURRENT BASIS AMENDED BASIS
1 (a) YES 1 (a) YES 1 (a) NO
1 (b) NO 1 (b) NO 1 (b) NO
44D NO 44D NO 44D NO
44E NO 44E NO 44E NO
66A NO 66A NO

NO BASIS NO NO BASIS NO


MARK DATA

STANDARD CHARACTER MARK NO
LITERAL MARK ELEMENT BAYER
MARK DRAWING CODE 3-AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/LETTER(S)/NUMBER(S)
COLOR DRAWING FLAG NO

CURRENT OWNER INFORMATION

PARTY TYPE 10-ORIGINAL APPLICANT
NAME Bayer Aktiengesellschaft
ADDRESS Kaiser-Wilhelm-Allee
51373 Leverkusen, 
ENTITY 99-aktiengesellschaft
CITIZENSHIP Germany

GOODS AND SERVICES

INTERNATIONAL CLASS 005
          DESCRIPTION TEXT house mark for a full line of pharmaceutical preparations; pharmaceutical preparations used for the relief of pain and to reduce fever; pharmaceutical preparations and substances for the prevention and/or treatment of cardiovascular diseases, hemophilia, metabolic diseases, cancer, multiple sclerosis, urologic diseases, sexual dysfunction, osteoporosis, and climacteric diseases; pharmaceutical preparations, namely, anticoagulants and platelet aggregation inhibitors; contraceptive preparations, analgesics, anti-pyretics, anti-inflammatory preparations, anti-septic preparations, medicated lip balm, anesthetic spray for topical use, astringents, pediculicides, decongestants, antifungal agents, antiinfective pharmaceutical preparations, antacids, cold preparations in the nature of preparations for treating colds, menstrual symptom treatment preparations and dermatologicals; vitamin and mineral supplements; calcium supplements; medical diagnostic reagents for the analysis of body fluids; preparations used in medical diagnostic procedures, namely, contrast media for use with x-ray, magnetic resonance and ultrasound equipment

GOODS AND SERVICES CLASSIFICATION

INTERNATIONAL CLASS 005 FIRST USE DATE 00/00/1929 FIRST USE IN COMMERCE DATE 00/00/1929 CLASS STATUS 6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS

CHANGE IN REGISTRATION NO
COLORS CLAIMED STATEMENT Color is not claimed as a feature of the mark.
DESCRIPTION OF MARK The mark consists of a circle containing the word "BAYER" appearing twice with each word intersecting with each other at the letter "Y" as if in a cross.
OWNER OF US REG NOS 2232456    3222255    3282854   

PROSECUTION HISTORY

DATE ENT CD ENT TYPE DESCRIPTION ENT NUM
05/15/2014 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED 011
05/15/2014 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE 010
05/09/2014 ALIE A ASSIGNED TO LIE 009
04/24/2014 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED 008
12/13/2013 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED 007
12/13/2013 GNRT F NON-FINAL ACTION E-MAILED 006
12/13/2013 CNRT R NON-FINAL ACTION WRITTEN 005
12/09/2013 DOCK D ASSIGNED TO EXAMINER 004
09/04/2013 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED 003
09/03/2013 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM 002
08/27/2013 NWAP I NEW APPLICATION ENTERED IN TRAM 001

CURRENT CORRESPONDENCE INFORMATION

ATTORNEY Jennifer Fraser
CORRESPONDENCE ADDRESS JENNIFER FRASER
NOVAK DRUCE CONNOLLY BOVE + QUIGG LLP
PO BOX 2207
WILMINGTON, DE 19899-2207
DOMESTIC REPRESENTATIVE Jennifer Fraser

Amendment and Mail Process Complete [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed